144 related articles for article (PubMed ID: 38376606)
21. DCUN1D1 facilitates tumor metastasis by activating FAK signaling and up-regulates PD-L1 in non-small-cell lung cancer.
Li J; Yu T; Yan M; Zhang X; Liao L; Zhu M; Lin H; Pan H; Yao M
Exp Cell Res; 2019 Jan; 374(2):304-314. PubMed ID: 30528265
[TBL] [Abstract][Full Text] [Related]
22. NRXN2 Possesses a Tumor Suppressor Potential via Inhibiting the Growth of Thyroid Cancer Cells.
Ma C; Zhang Y
Comput Math Methods Med; 2021; 2021():7993622. PubMed ID: 34777568
[TBL] [Abstract][Full Text] [Related]
23. Long non-coding RNA TTN-AS1 facilitates tumorigenesis of papillary thyroid cancer through modulating the miR-153-3p/ZNRF2 axis.
Cui Z; Luo Z; Lin Z; Shi L; Hong Y; Yan C
J Gene Med; 2019 May; 21(5):e3083. PubMed ID: 30811764
[TBL] [Abstract][Full Text] [Related]
24. KMT2B promotes SHPRH expression to regulate
Chen W; Zhong M; Yu J; Xie R; Zhou T; Zhang S; Xiong C; Huang D
Cell Signal; 2021 Dec; 88():110165. PubMed ID: 34606908
[TBL] [Abstract][Full Text] [Related]
25. Clinical and biological significance of Cdk10 in hepatocellular carcinoma.
Zhong XY; Xu XX; Yu JH; Jiang GX; Yu Y; Tai S; Wang ZD; Cui YF
Gene; 2012 Apr; 498(1):68-74. PubMed ID: 22326270
[TBL] [Abstract][Full Text] [Related]
26. Proyl isomerase Pin1 facilitates ubiquitin-mediated degradation of cyclin-dependent kinase 10 to induce tamoxifen resistance in breast cancer cells.
Khanal P; Yun HJ; Lim SC; Ahn SG; Yoon HE; Kang KW; Hong R; Choi HS
Oncogene; 2012 Aug; 31(34):3845-56. PubMed ID: 22158035
[TBL] [Abstract][Full Text] [Related]
27. Kruppel-like factor 13 acts as a tumor suppressor in thyroid carcinoma by downregulating IFIT1.
Liu Y; Song Y; He Y; Kong Z; Li H; Zhu Y; Liu S
Biol Direct; 2023 Oct; 18(1):65. PubMed ID: 37817224
[TBL] [Abstract][Full Text] [Related]
28. Key molecules associated with thyroid carcinoma prognosis: A study based on transcriptome sequencing and GEO datasets.
Bai M; Ke S; Yu H; Xu Y; Yu Y; Lu S; Wang C; Huang J; Ma Y; Dai W; Wu Y
Front Immunol; 2022; 13():964891. PubMed ID: 36059514
[TBL] [Abstract][Full Text] [Related]
29. PCDH8 is a novel prognostic biomarker in thyroid cancer and promotes cell proliferation and viability.
Yang R; Yang N; Yin P; Xue Z; Sun F; Fan R; Liang J; Lv X; Wu S; Sun L
Funct Integr Genomics; 2024 Feb; 24(2):35. PubMed ID: 38368303
[TBL] [Abstract][Full Text] [Related]
30. Long Non-Coding RNA LPP-AS2 Plays an Anti-Tumor Role in Thyroid Carcinoma by Regulating the miR-132-3p/OLFM1 Axis.
Zhang B; Liu T; Gu Y; Ren L; Wang J; Feng C; Song Z
Crit Rev Eukaryot Gene Expr; 2023; 33(5):73-86. PubMed ID: 37199315
[TBL] [Abstract][Full Text] [Related]
31. Mesenchymal stem cells-originated exosomal microRNA-152 impairs proliferation, invasion and migration of thyroid carcinoma cells by interacting with DPP4.
Tang M; Wang Q; Wang K; Wang F
J Endocrinol Invest; 2020 Dec; 43(12):1787-1796. PubMed ID: 32876927
[TBL] [Abstract][Full Text] [Related]
32. E2F, HSF2, and miR-26 in thyroid carcinoma: bioinformatic analysis of RNA-sequencing data.
Lu JC; Zhang YP
Genet Mol Res; 2016 Mar; 15(1):15017576. PubMed ID: 26985959
[TBL] [Abstract][Full Text] [Related]
33. Roles of Cadherin2 in Thyroid Cancer.
Chen Y; Hong C; Zhou Q; Qin Z
Front Oncol; 2022; 12():804287. PubMed ID: 35756646
[TBL] [Abstract][Full Text] [Related]
34. DNMT1/DNMT3a-mediated promoter hypermethylation and transcription activation of ICAM5 augments thyroid carcinoma progression.
Li Z; Ying Y; Zeng X; Liu J; Xie Y; Deng Z; Hu Z; Yang J
Funct Integr Genomics; 2024 Jan; 24(1):12. PubMed ID: 38228798
[TBL] [Abstract][Full Text] [Related]
35. NKD2 is correlated with the occurrence, progression and prognosis of thyroid carcinoma.
Gao Y; Wang Y; Guo R
Eur J Med Res; 2022 Nov; 27(1):235. PubMed ID: 36348408
[TBL] [Abstract][Full Text] [Related]
36. miR-183-5p promotes proliferation, invasion, and glycolysis of thyroid carcinoma cells by targeting FOXO1.
Han C; Mo K; Jiang L; Wang K; Teng L
Mol Cell Biochem; 2022 Apr; 477(4):1195-1206. PubMed ID: 35084673
[TBL] [Abstract][Full Text] [Related]
37. Mitofusin-2 modulates the epithelial to mesenchymal transition in thyroid cancer progression.
You MH; Jeon MJ; Kim SR; Lee WK; Cheng SY; Jang G; Kim TY; Kim WB; Shong YK; Kim WG
Sci Rep; 2021 Jan; 11(1):2054. PubMed ID: 33479369
[TBL] [Abstract][Full Text] [Related]
38. HSPA5 is a prognostic biomarker correlated with immune infiltrates in thyroid carcinoma.
Dong W; Du D; Huang H
Endokrynol Pol; 2022; 73(4):680-689. PubMed ID: 36059163
[TBL] [Abstract][Full Text] [Related]
39. The E3 ubiquitin ligase RNF115 regulates phagosome maturation and host response to bacterial infection.
Bilkei-Gorzo O; Heunis T; Marín-Rubio JL; Cianfanelli FR; Raymond BBA; Inns J; Fabrikova D; Peltier J; Oakley F; Schmid R; Härtlova A; Trost M
EMBO J; 2022 Dec; 41(23):e108970. PubMed ID: 36281581
[TBL] [Abstract][Full Text] [Related]
40. Identification of Key Pathways and Genes Downstream of Insulin-Like Growth Factor 1 in Thyroid Carcinoma.
Wang J; Wu L; Lu W; Zhang H; Wu Y
Genet Test Mol Biomarkers; 2022 Nov; 26(11):522-531. PubMed ID: 36440844
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
